Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single Arm, Open-Label Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients

NCT01199939 is registered in ClinicalTrials.gov with Tibotec, Inc as lead sponsor.

NCT NCT01199939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single Arm, Open-Label Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Lead sponsor
Tibotec, Inc
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
October 31, 2012
Enrollment
54 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)